• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Forth nightly review: hereditary ovarian carcinoma.第四次夜间查房：遗传性卵巢癌
BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786.
2
High frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jewish ovarian cancer patients.阿什肯纳兹犹太裔卵巢癌患者中BRCA1和BRCA2突变的高频率。
Gynecol Oncol. 1998 Jul;70(1):152. doi: 10.1006/gyno.1998.5007.
3
Breast & ovarian cancer. Issues in risk assessment.乳腺癌与卵巢癌。风险评估问题。
Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4.
4
Hereditary breast cancer.遗传性乳腺癌
Pol J Pathol. 1998;49(2):59-66.
5
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.与遗传性乳腺癌卵巢癌综合征家系中的非携带者相比，BRCA1和BRCA2突变携带者预防性切除卵巢的组织学情况。
Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861.
6
Complex decision-making for BRCA1/2 carriers.BRCA1/2基因携带者的复杂决策
Cancer J Sci Am. 1999 Sep-Oct;5(5):266-8.
7
Preventive gynecologic surgery for BRCA1/2 carriers--information for decision-making.BRCA1/2基因携带者的预防性妇科手术——决策信息
Gynecol Oncol. 2001 Oct;83(1):168-70. doi: 10.1006/gyno.2001.6381.
8
Chemoprevention of hereditary ovarian cancer.遗传性卵巢癌的化学预防
N Engl J Med. 1998 Aug 13;339(7):469-71. doi: 10.1056/NEJM199808133390710.
9
Oral contraceptives and hereditary ovarian cancer.
N Engl J Med. 1999 Jan 7;340(1):59; author reply 60. doi: 10.1056/NEJM199901073400113.
10
Differences between hereditary and sporadic ovarian cancer.遗传性卵巢癌与散发性卵巢癌的差异。
Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):151-3. doi: 10.1016/s0301-2115(98)00218-8.

引用本文的文献

1
Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.遗传性卵巢癌的分子遗传学与管理的最新进展：放射科医生入门指南
Abdom Radiol (NY). 2021 Jun;46(6):2281-2292. doi: 10.1007/s00261-020-02911-x. Epub 2021 Apr 13.
2
Ovarian cancer mortality among women aged 40-79 years in relation to reproductive factors and body mass index: latest evidence from the Japan Collaborative Cohort study.40-79 岁女性的卵巢癌死亡率与生殖因素和体重指数的关系：来自日本协作队列研究的最新证据。
J Gynecol Oncol. 2013 Jul;24(3):249-57. doi: 10.3802/jgo.2013.24.3.249. Epub 2013 Jul 4.
3
Molecular genetics of ovarian cancer.卵巢癌的分子遗传学
Mol Biotechnol. 2001 Sep;19(1):13-28. doi: 10.1385/MB:19:1:013.
4
What we could do now: molecular pathology of gynaecological cancer.我们目前所能做的：妇科癌症的分子病理学
Mol Pathol. 2001 Aug;54(4):222-4. doi: 10.1136/mp.54.4.222.

本文引用的文献

1
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.乳腺癌与激素替代疗法：对51项流行病学研究数据的联合重新分析，涉及52705例乳腺癌女性和108411例非乳腺癌女性。乳腺癌激素因素协作组
Lancet. 1997 Oct 11;350(9084):1047-59.
2
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.法裔加拿大乳腺癌和卵巢癌家族中的始祖BRCA1和BRCA2突变
Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099.
3
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.法裔加拿大人中家族性和散发性卵巢癌的危险因素：一项病例对照研究。
Am J Obstet Gynecol. 1998 Aug;179(2):403-10. doi: 10.1016/s0002-9378(98)70372-2.
4
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.口服避孕药与遗传性卵巢癌风险。遗传性卵巢癌临床研究组。
N Engl J Med. 1998 Aug 13;339(7):424-8. doi: 10.1056/NEJM199808133390702.
5
A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.三名卵巢癌患者的BRCA2基因发生错义突变。
Br J Cancer. 1998 Apr;77(8):1199-202. doi: 10.1038/bjc.1998.202.
6
Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.携带BRCA1基因种系突变的日本女性卵巢癌的临床特征
Clin Cancer Res. 1998 Jan;4(1):235-40.
7
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.乳腺癌家族中BRCA1和BRCA2基因的遗传异质性及外显率分析。乳腺癌连锁协会。
Am J Hum Genet. 1998 Mar;62(3):676-89. doi: 10.1086/301749.
8
Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.BRCA1基因相关乳腺癌和卵巢癌患者的生存率：一项基于瑞典南部人群的研究。
J Clin Oncol. 1998 Feb;16(2):397-404. doi: 10.1200/JCO.1998.16.2.397.
9
Is hereditary site-specific ovarian cancer a distinct genetic condition?
Am J Med Genet. 1998 Jan 6;75(1):55-8. doi: 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r.
10
BRCA2 mutations in hereditary breast and ovarian cancer in France.法国遗传性乳腺癌和卵巢癌中的BRCA2基因突变
Am J Hum Genet. 1997 May;60(5):1236-9.

Forth nightly review: hereditary ovarian carcinoma.

作者信息

Kasprzak L, Foulkes W D, Shelling A N

机构信息

Division of Medical Genetics, Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 1A4.

出版信息

BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786.

DOI:10.1136/bmj.318.7186.786
PMID:10082707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1115218/
Abstract
摘要